161 related articles for article (PubMed ID: 30455643)
1. Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety.
Engel O; Masic A; Landsberg G; Brooks M; Mills DS; Rundfeldt C
Front Pharmacol; 2018; 9():1225. PubMed ID: 30455643
[TBL] [Abstract][Full Text] [Related]
2. Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.
Packer RM; De Risio L; Volk HA
BMC Vet Res; 2017 Apr; 13(1):90. PubMed ID: 28388948
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.
Rundfeldt C; Löscher W
CNS Drugs; 2014 Jan; 28(1):29-43. PubMed ID: 24357084
[TBL] [Abstract][Full Text] [Related]
4. The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs.
Löscher W; Hoffmann K; Twele F; Potschka H; Töllner K
Pharmacol Res; 2013 Nov; 77():39-46. PubMed ID: 24056205
[TBL] [Abstract][Full Text] [Related]
5. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
[TBL] [Abstract][Full Text] [Related]
6. The use of imepitoin (Pexion™) on fear and anxiety related problems in dogs - a case series.
McPeake KJ; Mills DS
BMC Vet Res; 2017 Jun; 13(1):173. PubMed ID: 28610629
[TBL] [Abstract][Full Text] [Related]
7. Pilot Study on the Efficacy and Safety of Long-Term Oral Imepitoin Treatment for Control of (Thunder)Storm-Associated Noise Phobia/Noise Aversion in Dogs Using an Individualized-Dose Titration Approach.
Muñoz Amezcua AC; Jones JM; Griffith EH; Gruen ME
Animals (Basel); 2024 Feb; 14(4):. PubMed ID: 38396513
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs.
Engel O; Müller HW; Klee R; Francke B; Mills DS
J Vet Intern Med; 2019 Nov; 33(6):2675-2684. PubMed ID: 31568622
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.
Yokoyama F; Yamauchi M; Oyama M; Okuma K; Onozawa K; Nagayama T; Shinei R; Ishikawa M; Sato Y; Kakui N
Psychopharmacology (Berl); 2009 Aug; 205(2):177-87. PubMed ID: 19357839
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.
Kapus GL; Gacsályi I; Vegh M; Kompagne H; Hegedus E; Leveleki C; Hársing LG; Barkóczy J; Bilkei-Gorzó A; Lévay G
Psychopharmacology (Berl); 2008 Jun; 198(2):231-41. PubMed ID: 18363046
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous adverse drug reaction in a dog associated with imepitoin.
Royaux E; Bhatti S; De Cock H; Van Ham L; Kitshoff A; Vandenabeele S
Vet Dermatol; 2016 Apr; 27(2):118-21e32. PubMed ID: 26799469
[TBL] [Abstract][Full Text] [Related]
13. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
[TBL] [Abstract][Full Text] [Related]
16. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi.
Hui KM; Huen MS; Wang HY; Zheng H; Sigel E; Baur R; Ren H; Li ZW; Wong JT; Xue H
Biochem Pharmacol; 2002 Nov; 64(9):1415-24. PubMed ID: 12392823
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
[TBL] [Abstract][Full Text] [Related]
19. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
